QL
BCRX icon

Quarry LP’s BioCryst Pharmaceuticals BCRX Stock Holding History

Quarry LP’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.04K Buy
+404
New +$3.65K ﹤0.01% 1192
2026
Q1 		– Sell
-30,000
Closed -$234K – 1484
2025
Q4 		$234K Buy
+30,000
New +$217K 0.04% 249
2024
Q2 		– Sell
-20,000
Closed -$102K – 1805
2024
Q1 		$102K Buy
20,000
+11,000
+122% +$61.9K 0.02% 244
2023
Q4 		$53.9K Buy
+9,000
New +$52.2K 0.01% 306

Other funds holding BCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Quarry LP's BCRX Position: Q2 2026 in Review

Quarry LP opened a new position in BioCryst Pharmaceuticals (BCRX) in Q2 2026: 404 shares worth $4.04K. The stake represents ﹤0.01% of the portfolio and ranks #1192 among its holdings. This is a return to the name: Quarry LP previously reported a position in BCRX as recently as Q4 2025.

Quarry LP first reported a position in BCRX in Q4 2023 and has held it in 4 quarters since. The position peaked at $234K in Q4 2025. 318 funds tracked by Wall St. Rank hold BCRX as of Q2 2026.

  • Quarry LP held 404 shares of BioCryst Pharmaceuticals worth $4.04K as of Q2 2026.
  • BioCryst Pharmaceuticals was a new Quarry LP position in Q2 2026.
  • BioCryst Pharmaceuticals made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1192 holding.
  • Quarry LP first reported a position in BioCryst Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
  • Quarry LP's BioCryst Pharmaceuticals position peaked at $234K in Q4 2025.
  • 318 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.